Tarsus Pharmaceuticals OverviewTarsus Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for TARS.
Quarterly Other Income/Expense
-$3.20M
↓ 375.6% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$2.25M
↓ 46.64% YoY
Trailing 12 months ending Mar 31, 2026